Table 2.
Discontinuance criteria
| Serum UA >12.0 mg/dL |
| Onset of gout arthritis |
| Considered inappropriate to continue the study by investigators due to adverse side effects or serious adverse events |
| Needed to receive any prohibited concomitant drugs |
| Participant relocated or changed doctor |
| The participant decides they no longer wish to continue the study |
| Considered inappropriate to continue the study by investigators due to some other reason |
UA uric acid